Chimeric antigen receptor T‐cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis

Treatment with high‐dose chemotherapy followed by autologous stem cell transplantation (ASCT) is considered standard of care (SOC) second‐line treatment for relapsed or refractory large B‐cell lymphoma (LBCL). However, outcomes remain suboptimal. A systematic review and meta‐analysis of randomised c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shargian, Liat, Raanani, Pia, Yeshurun, Moshe, Gafter‐Gvili, Anat, Gurion, Ronit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematological Malignancy–Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542944/
https://www.ncbi.nlm.nih.gov/pubmed/35765220
http://dx.doi.org/10.1111/bjh.18335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542944/
https://www.ncbi.nlm.nih.gov/pubmed/35765220
http://dx.doi.org/10.1111/bjh.18335

Ejemplares similares